share_log

Strong Week for Danhua Chemical TechnologyLtd (SHSE:600844) Shareholders Doesn't Alleviate Pain of Five-year Loss

Strong Week for Danhua Chemical TechnologyLtd (SHSE:600844) Shareholders Doesn't Alleviate Pain of Five-year Loss

丹華化學技術有限公司(SHSE: 600844)股東本週表現強勁,但五年虧損的痛苦並未緩解五年虧損的痛苦
Simply Wall St ·  2023/11/15 17:47

Danhua Chemical Technology Co.,Ltd (SHSE:600844) shareholders should be happy to see the share price up 15% in the last month. But if you look at the last five years the returns have not been good. You would have done a lot better buying an index fund, since the stock has dropped 16% in that half decade.

丹華化學科技股份有限公司, Ltd(SHSE: 600844)的股東應該很高興看到股價在上個月上漲了15%。但是,如果你看看過去五年,回報並不理想。買入指數基金要好得多,因爲該股在那五年中下跌了16%。

While the stock has risen 15% in the past week but long term shareholders are still in the red, let's see what the fundamentals can tell us.

儘管該股在過去一週上漲了15%,但長期股東仍處於虧損狀態,但讓我們看看基本面能告訴我們什麼。

Check out our latest analysis for Danhua Chemical TechnologyLtd

查看我們對丹華化學科技有限公司的最新分析

Danhua Chemical TechnologyLtd isn't currently profitable, so most analysts would look to revenue growth to get an idea of how fast the underlying business is growing. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. That's because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size.

丹華化學科技有限公司目前沒有盈利,因此大多數分析師會關注收入增長,以了解基礎業務的增長速度。一般而言,沒有利潤的公司預計每年都會以不錯的速度增長收入。那是因爲可以很容易地推斷出快速的收入增長來預測利潤,而利潤通常規模相當大。

In the last five years Danhua Chemical TechnologyLtd saw its revenue shrink by 8.7% per year. That puts it in an unattractive cohort, to put it mildly. On the face of it we'd posit the share price fall of 3% compound, over five years is well justified by the fundamental deterioration. We doubt many shareholders are delighted with this share price performance. It is possible for businesses to bounce back but as Buffett says, 'turnarounds seldom turn'.

在過去五年中,丹華化工科技有限公司的收入每年下降8.7%。說得客氣一點,這使它屬於一個沒有吸引力的群體。從表面上看,我們假設股價複合下跌3%,基本面惡化是合理的。我們懷疑許多股東對這種股價表現感到高興。企業有可能反彈,但正如巴菲特所說,“轉機很少轉機”。

The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).

下圖描述了收入和收入隨時間推移而發生的變化(點擊圖片即可顯示確切的數值)。

earnings-and-revenue-growth
SHSE:600844 Earnings and Revenue Growth November 15th 2023
上海證券交易所:600844 2023年11月15日收益和收入增長

If you are thinking of buying or selling Danhua Chemical TechnologyLtd stock, you should check out this FREE detailed report on its balance sheet.

如果您想買入或賣出丹華化學科技有限公司的股票,則應查看這份有關其資產負債表的免費詳細報告。

A Different Perspective

不同的視角

We're pleased to report that Danhua Chemical TechnologyLtd shareholders have received a total shareholder return of 3.8% over one year. Notably the five-year annualised TSR loss of 3% per year compares very unfavourably with the recent share price performance. The long term loss makes us cautious, but the short term TSR gain certainly hints at a brighter future. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. To that end, you should be aware of the 2 warning signs we've spotted with Danhua Chemical TechnologyLtd .

我們很高興地向大家報告,丹華化學科技有限公司的股東在一年內獲得了3.8%的股東總回報率。值得注意的是,五年期年化股東總回報率每年虧損3%,與最近的股價表現相比非常不利。長期虧損使我們持謹慎態度,但短期股東總回報率的上漲無疑預示着更光明的未來。儘管值得考慮市場狀況可能對股價產生的不同影響,但還有其他因素更爲重要。爲此,您應該注意我們在丹華化學科技有限公司發現的兩個警告信號。

If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.

如果你像我一樣,那麼你不會想錯過這份業內人士正在收購的成長型公司的免費名單。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

請注意,本文引用的市場回報反映了目前在中國交易所交易的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論